Boston Biopharma, Inc. — Form D
Boston Biopharma, Inc. of ROSWELL, GA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-29. $1.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-04-29
- Form: D
- Accession: 0001857036-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $1.5M
- Investors: 15
- Date of first sale: 2020-03-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-397638
Issuer
- Name: Boston Biopharma, Inc.
- CIK: 0001857036
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 570 COLONIAL PARK DRIVE, SUITE 309, ROSWELL, GA, 30075
- Phone: 5082190200
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Terry Kevin Clark | Director | Palmer, AK |
| Ahmad Hashem | Director | Roswell, GA |
| Ammar Kevin Hemaidan | Director | Port Orange, FL |
| Peter Gerhard Wodtke | Director | Washington, CT |
| Ahmad Hashem | Executive Officer | Roswell, GA |
More